polymorphism
Survey: Challenges in Polymorphism and Crystallisation 2011
April 27 by Pharma IQ SurveysPharma IQ has put together this short 7 question survey to find out the top challenges in polymorphism and crystallisation that the industry faces. Take part to share your professional opinion on th...
The Impact of Direct Nucleation Control on Crystal Size Distribution in Pharmaceutical Crystallization Processes
January 25 by Pharmaceuticals & Biotechnology EditorThe control of crystal size distribution (CSD) in pharmaceutical crystallization is of primary importance, as downstream processes such as filtration or drying are greatly affected by the properties...
92.9% Think Polymorphism and Crystallisation is the Greatest Challenge They Face
November 24 by Pharmaceuticals & Biotechnology EditorPolymorphism and crystallisation are considered to be one of the most significant and demanding areas of pharmaceutical development. New discoveries have the potential to either give organisations a...
5 Things You Need to Know about Continuous Pharmaceutical Manufacturing
November 15 by Andrea Charles“Continuous manufacturing is done in almost all manufacturing industries, except for wine, hard spirits, and pharmaceuticals. Defining a batch is up to the manufacturer but consistent with QbD...
Polymorphism and Crystallisation in Modern Pharmaceuticals
November 02 by Pharma IQPolymorphism and crystallisation are among the most important and challenging areas of pharmaceuticals today, with new polymorph discoveries harbouring the potential to dramatically change the prope...
Improving Pharmaceuticals Through Co-Crystals
September 08 by Pharma IQIn this podcast Dr. Nair Rodriguez-Hornedo, Professor, Department of Pharmaceutical Sciences at the University of Michigan, speaks to Andrea Charles from Pharma IQ, about how can we improve pharmaceut...
Pfizer, Sanofi-Aventis, Novartis, GlaxoSmithKline, Abbott Laboratories and Merck to Speak at the 9th Polymorphism & Crystallization Scientific Forum
August 24 by Pharma IQ NewsThere has been increased focus on using crystals and the ever-changing, sometimes disappearing properties of polymorphs as significant scientific and business opportunities. IQPC’s Polymor...
Be Prepared for Scale Up of Co-crystal Production
July 06 by Vaibhav SihorkarDr. Vaibhav Sihorkar, Head of Pharmaceutical Development at Aurigene Discovery Technologies in India, gave Pharma IQ his insights on existing challenges to co-crystal commercialisation. Wha...